Regulatory and AI Round-Up: Week of 3 August 2026
This regulatory round‑up highlights the FDA’s revised medical device human factors guidance, effective August 3, 2026, which impacts how AI‑enabled clinical tools are designed and documented. The update changes key definitions, shortens documentation requirements, and removes the prior eight‑section report outline, signaling a shift in expectations for usability and safety evidence in AI‑driven medical devices.
About LOG Standards
LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.
Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.